Unmasking a hepatitis C genotype 3a/1b dual infection in an individual treated with elbasvir/grazoprevir

J Hepatol. 2023 Mar;78(3):e95-e96. doi: 10.1016/j.jhep.2022.11.016. Epub 2022 Nov 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C* / drug therapy
  • Hepatitis C, Chronic* / drug therapy
  • Humans
  • Quinoxalines / therapeutic use
  • Sulfonamides / therapeutic use

Substances

  • grazoprevir
  • elbasvir
  • Sulfonamides
  • Quinoxalines
  • Antiviral Agents